Insider

Intuitive Surgical insiders sold shares in September 2026

In September 2026, two Intuitive Surgical executives sold shares under Rule 10b5‑1 plans. Mark Brosius, executive vice president and chief manufacturing and supply chain officer, sold 48 shares for $17,140.93 on September 10‑11. Fredrik Widman, vice president, corporate controller, sold 1,089 shares for $407,765.16 on September 15.

Verified against 3 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
a long hallway with pictures on the walls
Photo by zhang shuaizhang on Unsplash
$407,765.16
Widman sale value
1,089 shares
Shares sold
$17,140.93
Brosius sale value

Key points

  • According to Form 4 (a filing that reports insider trading, period of report 2026‑09‑10), Mark Brosius reported two open market sales on September 10‑11.
  • Both sales were made under a Rule 10b5‑1 plan (a preset selling schedule executives set up in advance), which is typically used to avoid trading on material non‑public information.
  • If the sales are part of pre‑approved plans, they likely reflect liquidity needs rather than a negative view of the business, so investors may view them as neutral events.

What happened

According to Form 4 (a filing that reports insider trading, period of report 2026‑09‑10), Mark Brosius reported two open market sales on September 10‑11. He sold 48 shares for $17,140.93 at a weighted average price of $357.1027; after the transaction he held 764 shares.

According to Form 4 (period of report 2026‑09‑15), Fredrik Widman reported two types of transactions on September 15. First, he acquired 1,089 shares through option exercises (value $102,932.92), then sold 1,089 shares (value $407,765.16); after the sale he retained 1,026 shares and 1,086 derivative securities.

Intuitive Surgical insider sales in September 2026

Mark Brosius$17,140.93Fredrik Widman$407,765.16
Data from the original sources listed alongside.

Why it matters

Both sales were made under a Rule 10b5‑1 plan (a preset selling schedule executives set up in advance), which is typically used to avoid trading on material non‑public information. The plan does not guarantee insiders lacked such information.

When this may help investors

If the sales are part of pre‑approved plans, they likely reflect liquidity needs rather than a negative view of the business, so investors may view them as neutral events.

Risks and unknowns

The motivation for the sales, especially the large volume by Widman, remains unclear; a negative market perception could affect the share price, though this is not confirmed by other data.

What to watch

Watch subsequent Form 4 and Form 144 filings (a notice of a proposed sale) and changes in insider holdings to confirm whether trading continues under Rule 10b5‑1.

Original sources

  1. 4 filing, September 11, 2026September 11, 2026SHA-256 of our archived copy 25e065829179…
  2. 144 filing, September 15, 2026September 15, 2026SHA-256 of our archived copy 8819f7ff3839…
  3. 4 filing, September 16, 2026September 16, 2026SHA-256 of our archived copy 19b07225cd1a…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards